TY - JOUR T1 - Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00021-2019 VL - 5 IS - 2 SP - 00021-2019 AU - Sofie Lock Johansson AU - Helle Wulf-Johansson AU - Anders Schlosser AU - Ingrid L. Titlestad AU - Bruce Miller AU - Ruth Tal-Singer AU - Uffe Holmskov AU - Jørgen Vestbo AU - Grith Lykke Sørensen Y1 - 2019/04/01 UR - http://openres.ersjournals.com/content/5/2/00021-2019.abstract N2 - Chronic obstructive pulmonary disease (COPD) is characterised by chronic airflow limitation and inflammation of the airways and lung parenchyma. COPD is associated with many comorbidities, especially cardiovascular disease (CVD), which share similar risk factors with COPD [1].Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g ER -